Improving Clinical Outcomes in Cancer Care

AI Predicts Cancer Metastasis with 80% Accuracy

Researchers at the University of Geneva develop MangroveGS to estimate tumor spread and prevent overtreatment.

By Avantgarde News Desk··1 min read
A digital visualization of a gene-expression analysis overlaying a medical scan, representing the MangroveGS AI model's ability to predict cancer spread.

A digital visualization of a gene-expression analysis overlaying a medical scan, representing the MangroveGS AI model's ability to predict cancer spread.

Photo: Avantgarde News

Researchers at the University of Geneva (UNIGE) developed an AI tool called MangroveGS to predict the risk of cancer metastasis [1][2]. The model analyzes gene-expression signatures to estimate how likely a tumor is to spread to other organs [1]. This development was recently published in the journal Cell Reports [1][2]. The model demonstrates nearly 80% accuracy in predicting metastasis and recurrence specifically for colon cancer [1][2]. Beyond colon cancer, researchers found the tool shows significant promise for evaluating stomach, lung, and breast cancers [1][3]. MangroveGS aims to assist clinicians in personalizing treatments for patients [2]. By identifying low-risk individuals, the tool could potentially prevent unnecessary and heavy treatments, such as chemotherapy, for those unlikely to experience recurrence [1][3].

Editorial notes

Transparency note

Drafted with LLM; human-edited

AI assisted
Yes
Human review
Yes
Last updated

Risk assessment

Minimal

Reviewed for sourcing quality and editorial consistency.

Sources

Related stories

View all

Topics

Get the weekly briefing

Weekly brief with top stories and market-moving news.

No spam. Unsubscribe anytime. By joining, you agree to our Privacy Policy.

About the author

Avantgarde News Desk covers improving clinical outcomes in cancer care and editorial analysis for Avantgarde News.